“…These findings are consistent with the results of the fecal metabolome analysis in which parishin treatment reversed the aging-induced depletion of 3-(3-hydroxyphenyl)-propanoic acid, L-proline, 4-hydroxybenzeneacetic acid and 5-aminovaleric acid. 5-Aminovaleric acid, the γ-aminobutyric acid (GABA) analog, is an important intermediate in the pathways of L-lysine degradation and L-proline degradation ( Burgardt et al, 2021 ; Cheng et al, 2021 ); the microbial flavonoid metabolite 4-hydroxybenzeneacetic acid, which possesses anxiolytic effects, is generated from gut microbial polyphenol and amino acid metabolism, and is an important intermediate in the pathways of L-tyrosine degradation and automatic biogenic amine degradation ( Zabela et al, 2016 ; Orabi et al, 2021 ); 3-(3-hydroxyphenyl)-propanoic acid, which has been reported to exhibit hepatoprotective activities by regulating oxidative stress, lipid peroxidation, and inflammatory responses ( Cui et al, 2018 ), is an intermediate in the phosphatidylcholine resynthesis pathway and in the mitochondrial NADPH production pathway of the cofactor, carrier, and vitamin biosynthesis superfamily. In addition, the parishin treatment-improved metabolite β-sitosterol is a plant-derived natural bioactive compound with various pharmacological activities, such as hypolipidemic, anti-inflammatory, antitumor, tissue repair and antiaging activities ( Haiyuan et al, 2019 ; Cheng et al, 2020 ), and is used to treat fatty liver, type II diabetes, and arthritis ( Gumede et al, 2020 ; Ramalingam et al, 2020 ).…”